To further define the mechanism by which SSA inhibits TGFβ signaling, the phosphorylation of Smad2 and Smad3 was measured in MCF-7 breast tumor cells following the treatment with TGFβ1. This evidence concerns the gene SMAD2 and breast neoplasm.